BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26281012)

  • 1. Development and validation of an epidermolysis bullosa family/parental burden score.
    Dufresne H; Hadj-Rabia S; Taieb C; Bodemer C
    Br J Dermatol; 2015 Dec; 173(6):1405-10. PubMed ID: 26281012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic dermatitis burden scale: creation of a specific burden questionnaire for families.
    Méni C; Bodemer C; Toulon A; Merhand S; Perez-Cullell N; Branchoux S; Taieb C
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1426-32. PubMed ID: 23675975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure.
    Salamon G; Strobl S; Field-Werners U; Diem A; Schwieger-Briel A; Pope E
    Br J Dermatol; 2024 Jun; 191(1):75-81. PubMed ID: 38261404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument.
    Frew JW; Martin LK; Nijsten T; Murrell DF
    Br J Dermatol; 2009 Dec; 161(6):1323-30. PubMed ID: 19681875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in patients with epidermolysis bullosa.
    Tabolli S; Sampogna F; Di Pietro C; Paradisi A; Uras C; Zotti P; Castiglia D; Zambruno G; Abeni D
    Br J Dermatol; 2009 Oct; 161(4):869-77. PubMed ID: 19624546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Quality of Life in Epidermolysis Bullosa" and "Epidermolysis Bullosa Burden of Disease": Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires.
    Hachem ME; Diociaiuti A; Zambruno G; Samela T; Ferretti F; Carnevale C; Linertová R; Bodemer C; Murrell DF; Abeni D
    Ital J Pediatr; 2024 Apr; 50(1):76. PubMed ID: 38637879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemangioma family burden: creation of a specific questionnaire.
    Boccara O; Méni C; Léauté-Labreze C; Bodemer C; Voisard JJ; Dufresne H; Brauchoux S; Taieb C
    Acta Derm Venereol; 2015 Jan; 95(1):78-82. PubMed ID: 24676555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese.
    Cestari T; Prati C; Menegon DB; Prado Oliveira ZN; Machado MC; Dumet J; Nakano J; Murrell DF
    Int J Dermatol; 2016 Feb; 55(2):e94-9. PubMed ID: 26474322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.
    Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R
    Indian J Dermatol Venereol Leprol; 2022; 88(2):177-183. PubMed ID: 34491666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family burden of children suffering from epidermolysis bullosa.
    DE Stefano S; Grassi FS; Lalatta F; Scuvera G; Brena M; Grillo P; Peves Rios WE; Guez S
    Ital J Dermatol Venerol; 2021 Oct; 156(5):580-587. PubMed ID: 33034432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of caregivers and out-of-pocket expenditures related to epidermolysis bullosa in France.
    Bourrat E; Taieb C; Marquié A; Causse P; Bergqvist C; Sauvestre A; Bellon N
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):194-203. PubMed ID: 35994204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population.
    Yuen WY; Frew JW; Veerman K; van den Heuvel ER; Murrell DF; Jonkman MF
    Acta Derm Venereol; 2014 Jul; 94(4):442-7. PubMed ID: 24337132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size.
    Fine JD; Johnson LB; Weiner M; Suchindran C
    Br J Dermatol; 2005 May; 152(5):1009-14. PubMed ID: 15888161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).
    Loh CC; Kim J; Su JC; Daniel BS; Venugopal SS; Rhodes LM; Intong LR; Law MG; Murrell DF
    J Am Acad Dermatol; 2014 Jan; 70(1):89-97.e1-13. PubMed ID: 24355263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire.
    Chernyshov PV; Marron SE; Tomas-Aragones L; Pustišek N; Gedeon I; Suru A; Tiplica GS; Salavastru CM; Nikolić M; Kakourou T; Valari M; Yordanova I; Darlenski R; Sampogna F
    Dermatol Ther; 2020 Nov; 33(6):e14128. PubMed ID: 32761748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Birmingham Epidermolysis Bullosa Severity score: development and validation.
    Moss C; Wong A; Davies P
    Br J Dermatol; 2009 May; 160(5):1057-65. PubMed ID: 19434791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical and psychological problems for parents of children with epidermolysis bullosa.
    Lansdown R; Atherton D; Dale A; Sproston S; Lloyd J
    Child Care Health Dev; 1986; 12(4):251-6. PubMed ID: 3742737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Impact of Epidermolysis Bullosa on Parents and Caregivers: A Cross-Cultural Validation of the Epidermolysis Bullosa Burden of Disease Questionnaire.
    Alheggi A; Alfahhad A; Bukhari A; Bodemer C
    Clin Cosmet Investig Dermatol; 2024; 17():1027-1032. PubMed ID: 38737942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family burden in epidermolysis bullosa is high independent of disease type/subtype.
    Tabolli S; Pagliarello C; Uras C; Di Pietro C; Zambruno G; Castiglia D; Sampogna F; Abeni D
    Acta Derm Venereol; 2010 Nov; 90(6):607-11. PubMed ID: 21057744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.